Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter revision label updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check21 days agoChange DetectedThe additions primarily add publication notes (voluntary input and PubMed autofill) and a new Revision: v3.3.1, while deletions remove older related topics and an older revision note (Revision: v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedA new study site was added: Tainan, Taiwan, 7428, and the old site entry Tainan City, Taiwan, 7428 was removed along with a funding-status notice.SummaryDifference0.1%

- Check43 days agoChange DetectedNo significant changes in core content or structure are evident between the two screenshots. Only minor, non-functional visual adjustments are visible; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page's related topics section.SummaryDifference0.0%

- Check58 days agoChange DetectedRemoved MedlinePlus Genetics topic: Non-alcoholic fatty liver disease.SummaryDifference0.1%

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.